Priority Date: 01.03.12 (EP 20120157680)

RHOGEF12 IS A THERAPEUTIC TARGET FOR THE TREATMENT OF HEART FAILURE

  • Application ID: EP13706573
  • Status: EXAMINATION IN PROGRESS

Attorney

Employment test 51 - 200 employees
Company dna vossius and partner
operating since 1961
Headquarter in Munich and 3 offices
active in Legal Services and IP-related Communication Service

Specialization

This patent has the IPC combination A01, A61, and C12 is specialized in the combination A01, A61, and C12. We found, that Sperling Fischer & Heyner, Zacco Denmark A/S, Isenbruck Bösl Hörschler LLP, Uexküll & Stolberg Partnerschaft von Patent- und Rechtsanwälten mbB, dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB and 35 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 01.03.2012 - Priority Date (EP 20120157680)
  • 06.09.2013 - Publication A1 (WO2013128025)
  • 07.01.2015 - Publication A1 (EP2820130)

IPC Classification